RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancerKe Hui(First Affiliated Hospital of Xi'an Jiaotong University), Kaijie Wu(First Affiliated Hospital of Xi'an Jiaotong University)Cell Death and DiseaseFebruary 9, 201710.1038/cddis.2017.9Cited by 57SaveCiteExport RISWatch citationsRelated PapersThe expression and function of RASAL2 in renal cell carcinoma angiogenesis|Cell Death and Disease|2018|252'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer|Oncology Reports|2018|13